Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-28 @ 5:00 AM
Study NCT ID:
NCT01451268
Status:
UNKNOWN
Last Update Posted:
2018-03-20
First Post:
2011-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-04
Completion Date Type:
ESTIMATED
First Submit Date:
2011-09-30
First Submit QC Date:
None
Study First Post Date:
2011-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-19
Last Update Post Date:
2018-03-20
Last Update Post Date Type:
ACTUAL